Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	fructose-bisphosphate aldolase activity	ALDOA ALDOB ALDOC	1.11e-06	3	208	3	GO:0004332
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	STARD13 GBF1 TRIO CYTH3 CYTH2 RUNDC3A DLC1 ARHGAP31 SIPA1L2 TBCD AGAP3 DOCK2 RANGAP1 GARNL3 SMCR8 GPSM1 SPATA13	2.45e-05	507	208	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	STARD13 GBF1 TRIO CYTH3 CYTH2 RUNDC3A DLC1 ARHGAP31 SIPA1L2 TBCD AGAP3 DOCK2 RANGAP1 GARNL3 SMCR8 GPSM1 SPATA13	2.45e-05	507	208	17	GO:0030695
GeneOntologyMolecularFunction	ATP-dependent activity	MYH6 ABCF1 VWA8 ACSS1 KATNAL1 ABCA9 ACSL1 ATAD2B DNAH8 KIF13B KIF27 KIF26B CCT7 DNAH7 ATP8B2 KIF20A MLH3 SLFN13 ACSL5	2.46e-05	614	208	19	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH6 MYO18B DNAH8 KIF13B KIF27 KIF26B DNAH7 KIF20A	3.33e-05	118	208	8	GO:0003774
GeneOntologyMolecularFunction	microtubule motor activity	DNAH8 KIF13B KIF27 KIF26B DNAH7 KIF20A	8.95e-05	70	208	6	GO:0003777
GeneOntologyMolecularFunction	aldehyde-lyase activity	ALDOA ALDOB ALDOC	1.73e-04	11	208	3	GO:0016832
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCF1 VWA8 KATNAL1 ABCA9 ATAD2B DNAH8 KIF13B KIF27 CCT7 DNAH7 ATP8B2 KIF20A MLH3 SLFN13	2.28e-04	441	208	14	GO:0016887
GeneOntologyMolecularFunction	hedgehog family protein binding	PTCH1 SCUBE2	6.39e-04	4	208	2	GO:0097108
GeneOntologyMolecularFunction	oleoyl-CoA ligase activity	ACSL1 ACSL5	6.39e-04	4	208	2	GO:0090434
GeneOntologyMolecularFunction	GTPase activator activity	STARD13 DLC1 ARHGAP31 SIPA1L2 TBCD AGAP3 DOCK2 RANGAP1 GARNL3 SMCR8	7.17e-04	279	208	10	GO:0005096
GeneOntologyMolecularFunction	glucokinase activity	HK3 GCK	1.06e-03	5	208	2	GO:0004340
GeneOntologyMolecularFunction	hexokinase activity	HK3 GCK	1.06e-03	5	208	2	GO:0004396
GeneOntologyMolecularFunction	fructokinase activity	HK3 GCK	1.06e-03	5	208	2	GO:0008865
GeneOntologyMolecularFunction	initiator methionyl aminopeptidase activity	METAP1D METAP2	1.06e-03	5	208	2	GO:0004239
GeneOntologyBiologicalProcess	fructose 1,6-bisphosphate metabolic process	PFKP ALDOA ALDOB ALDOC	1.24e-06	9	209	4	GO:0030388
GeneOntologyBiologicalProcess	glycolytic process through fructose-6-phosphate	HK3 GCK PFKP ALDOA ALDOB	1.40e-05	31	209	5	GO:0061615
GeneOntologyBiologicalProcess	NADH regeneration	HK3 GCK PFKP ALDOA	5.36e-05	21	209	4	GO:0006735
GeneOntologyBiologicalProcess	canonical glycolysis	HK3 GCK PFKP ALDOA	5.36e-05	21	209	4	GO:0061621
GeneOntologyBiologicalProcess	glucose catabolic process to pyruvate	HK3 GCK PFKP ALDOA	5.36e-05	21	209	4	GO:0061718
GeneOntologyBiologicalProcess	NADH metabolic process	HK3 GCK PFKP ALDOA ALDOB	6.38e-05	42	209	5	GO:0006734
GeneOntologyBiologicalProcess	NAD catabolic process	HK3 GCK PFKP ALDOA	1.10e-04	25	209	4	GO:0019677
GeneOntologyBiologicalProcess	glycolytic process through glucose-6-phosphate	HK3 GCK PFKP ALDOA	1.10e-04	25	209	4	GO:0061620
Domain	FBA_I	ALDOA ALDOB ALDOC	1.38e-06	3	209	3	IPR000741
Domain	Glycolytic	ALDOA ALDOB ALDOC	1.38e-06	3	209	3	PF00274
Domain	Aldolase_I_AS	ALDOA ALDOB ALDOC	1.38e-06	3	209	3	IPR029768
Domain	ALDOLASE_CLASS_I	ALDOA ALDOB ALDOC	1.38e-06	3	209	3	PS00158
Domain	zf-C2H2_6	ZNF836 ZNF324 ZNF770 ZFP62 ZNF48 ZNF329 ZNF181 GZF1 ZNF197 ZNF790 ZNF420 ZFP92 ZNF44	5.60e-05	314	209	13	PF13912
Domain	TSP_1	SSPOP ADAMTS15 C9 SEMA5A THSD7B ADAMTS7	7.30e-05	63	209	6	PF00090
Domain	TSP1	SSPOP ADAMTS15 C9 SEMA5A THSD7B ADAMTS7	8.71e-05	65	209	6	SM00209
Domain	TSP1_rpt	SSPOP ADAMTS15 C9 SEMA5A THSD7B ADAMTS7	8.71e-05	65	209	6	IPR000884
Domain	TSP1	SSPOP ADAMTS15 C9 SEMA5A THSD7B ADAMTS7	8.71e-05	65	209	6	PS50092
Domain	Pept_M24_MAP	METAP1D METAP2	3.71e-04	3	209	2	IPR001714
Domain	-	GBF1 CYTH3 CYTH2	5.69e-04	15	209	3	1.10.1000.11
Domain	Sec7	GBF1 CYTH3 CYTH2	5.69e-04	15	209	3	PF01369
Domain	Sec7_alpha_orthog	GBF1 CYTH3 CYTH2	5.69e-04	15	209	3	IPR023394
Domain	-	ZNF585A ZNF274 ZFP3 ZNF829 ZNF836 ZNF324 ZNF770 ZFP62 ZNF48 ZNF329 ZNF181 GZF1 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	6.48e-04	679	209	18	3.30.160.60
Domain	SEC7	GBF1 CYTH3 CYTH2	6.95e-04	16	209	3	PS50190
Domain	Sec7	GBF1 CYTH3 CYTH2	6.95e-04	16	209	3	SM00222
Domain	Sec7_dom	GBF1 CYTH3 CYTH2	6.95e-04	16	209	3	IPR000904
Domain	KRAB	ZNF585A ZNF274 ZNF829 ZNF836 ZNF324 ZNF181 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	7.36e-04	358	209	12	PS50805
Domain	KRAB	ZNF585A ZNF274 ZNF829 ZNF836 ZNF324 ZNF181 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	7.36e-04	358	209	12	PF01352
Domain	HJURP_C	HJURP MEF2D	7.37e-04	4	209	2	IPR022102
Domain	Argonaute_N	AGO2 AGO4	7.37e-04	4	209	2	IPR032474
Domain	Argonaute_Mid_dom	AGO2 AGO4	7.37e-04	4	209	2	IPR032473
Domain	ArgoL2	AGO2 AGO4	7.37e-04	4	209	2	IPR032472
Domain	HJURP_C	HJURP MEF2D	7.37e-04	4	209	2	PF12347
Domain	ArgoN	AGO2 AGO4	7.37e-04	4	209	2	PF16486
Domain	ArgoMid	AGO2 AGO4	7.37e-04	4	209	2	PF16487
Domain	ArgoL2	AGO2 AGO4	7.37e-04	4	209	2	PF16488
Domain	zf-C2H2	ZNF585A ZNF274 ZFP3 ZNF829 ZNF836 ZNF324 ZNF770 ZFP62 ZNF48 ZNF329 ZNF181 GZF1 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	8.20e-04	693	209	18	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF585A ZNF274 ZFP3 ZNF829 ZNF836 ZNF324 ZNF770 ZFP62 ZNF48 ZNF329 ZNF181 GZF1 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	8.34e-04	694	209	18	IPR013087
Domain	KRAB	ZNF585A ZNF274 ZNF829 ZNF836 ZNF324 ZNF181 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	9.57e-04	369	209	12	SM00349
Domain	KRAB	ZNF585A ZNF274 ZNF829 ZNF836 ZNF324 ZNF181 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	9.80e-04	370	209	12	IPR001909
Domain	AAA	ABCF1 VWA8 KATNAL1 ABCA9 ATAD2B DNAH8 DNAH7	1.20e-03	144	209	7	SM00382
Domain	AAA+_ATPase	ABCF1 VWA8 KATNAL1 ABCA9 ATAD2B DNAH8 DNAH7	1.20e-03	144	209	7	IPR003593
Domain	Hexokinase_2	HK3 GCK	1.22e-03	5	209	2	PF03727
Domain	Hexokinase_BS	HK3 GCK	1.22e-03	5	209	2	IPR019807
Domain	Cyt_c1_TM_anchor_C	UGDH NECTIN3	1.22e-03	5	209	2	IPR021157
Domain	Hexokinase_C	HK3 GCK	1.22e-03	5	209	2	IPR022673
Domain	Hexokinase_N	HK3 GCK	1.22e-03	5	209	2	IPR022672
Domain	Hexokinase_1	HK3 GCK	1.22e-03	5	209	2	PF00349
Domain	HEXOKINASE_2	HK3 GCK	1.22e-03	5	209	2	PS51748
Domain	DUF1785	AGO2 AGO4	1.22e-03	5	209	2	SM01163
Domain	HEXOKINASE_1	HK3 GCK	1.22e-03	5	209	2	PS00378
Domain	Kinesin-like_fam	KIF13B KIF27 KIF26B KIF20A	1.34e-03	43	209	4	IPR027640
Domain	P-loop_NTPase	DLG5 MYH6 ABCF1 VWA8 KATNAL1 ABCA9 ATAD2B NLRC5 MYO18B DNAH8 RAB26 AGAP3 KIF13B KIF27 KIF26B HNRNPUL1 DNAH7 KIF20A RAB36 SLFN13	1.38e-03	848	209	20	IPR027417
Domain	-	KIF13B KIF27 KIF26B KIF20A	1.46e-03	44	209	4	3.40.850.10
Domain	Kinesin	KIF13B KIF27 KIF26B KIF20A	1.46e-03	44	209	4	PF00225
Domain	KISc	KIF13B KIF27 KIF26B KIF20A	1.46e-03	44	209	4	SM00129
Domain	KINESIN_MOTOR_1	KIF13B KIF27 KIF26B KIF20A	1.46e-03	44	209	4	PS00411
Domain	Kinesin_motor_dom	KIF13B KIF27 KIF26B KIF20A	1.46e-03	44	209	4	IPR001752
Domain	KINESIN_MOTOR_2	KIF13B KIF27 KIF26B KIF20A	1.46e-03	44	209	4	PS50067
Domain	SRCR	CD163 CD163L1 PRSS12	1.58e-03	21	209	3	PF00530
Domain	Hexokinase	HK3 GCK	1.81e-03	6	209	2	IPR001312
Domain	ArgoL1	AGO2 AGO4	1.81e-03	6	209	2	PF08699
Domain	ArgoL1	AGO2 AGO4	1.81e-03	6	209	2	IPR014811
Pathway	KEGG_GLYCOLYSIS_GLUCONEOGENESIS	HK3 ACSS1 GCK PFKP ALDOA ALDOB ALDOC	6.20e-06	62	160	7	M11521
Pathway	WP_GLYCOLYSIS_AND_GLUCONEOGENESIS	HK3 GCK PFKP ALDOA ALDOB ALDOC	1.10e-05	45	160	6	M39474
Pathway	WP_GLYCOLYSIS_AND_GLUCONEOGENESIS	HK3 GCK PFKP ALDOA ALDOB ALDOC	2.30e-05	51	160	6	MM15928
Pathway	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	HK3 PFKP ALDOA ALDOB ALDOC	3.77e-05	34	160	5	M15898
Pathway	WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS	HK3 PFKP LDHD KDR ALDOA ALDOB ALDOC	5.39e-05	86	160	7	M39375
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	SSPOP ADAMTS15 SEMA5A THSD7B ADAMTS7	7.46e-05	39	160	5	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	SSPOP ADAMTS15 SEMA5A THSD7B ADAMTS7	7.46e-05	39	160	5	MM15165
Pathway	WP_METABOLIC_EPILEPTIC_DISORDERS	HK3 GCK PFKP ALDOA ALDOB ALDOC CBS	7.75e-05	91	160	7	M48079
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOLYSIS	PFKP ALDOA ALDOB ALDOC	1.68e-04	25	160	4	M47623
Pathway	WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS	HK3 GCK UGDH	2.21e-04	11	160	3	M48094
Pathway	KEGG_PENTOSE_PHOSPHATE_PATHWAY	PFKP ALDOA ALDOB ALDOC	2.29e-04	27	160	4	M1386
Pathway	BIOCARTA_ARAP_PATHWAY	GBF1 CYTH3 CYTH2	2.93e-04	12	160	3	MM1342
Pathway	REACTOME_GLUCOSE_METABOLISM	HK3 GCK PFKP ALDOA ALDOB ALDOC	3.35e-04	82	160	6	MM15394
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM5B ABCF1 TRIO HIPK1 CYTH3 ZMYM2 CMYA5 ZNF836 DST SACS ALDOA QKI KDM6A METAP2 AGAP3 ANK2 ZNF329 HECTD4 CCT7 OAT HNRNPUL1 CBS ZNF181 MRFAP1 ZNF197 ZNF565 CADPS2 USP33	8.19e-09	1285	215	28	35914814
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	GBF1 TRIO PSMB3 PFKP ZC3H6 MYEF2 FAT1 UBN1 QKI USP48 TBCD COL12A1 COL16A1 KIF26B CIP2A CBS ZCCHC3 KIF20A SHCBP1	6.93e-08	689	215	19	36543142
Pubmed	An analysis of expression patterns of genes encoding proteins with catalytic activities.	HK3 ACSS1 GCK PFKP ALDOA ALDOB ALDOC	1.99e-07	67	215	7	17626619
Pubmed	Mode of interactions of human aldolase isozymes with cytoskeletons.	ALDOA ALDOB ALDOC	2.33e-07	3	215	3	9244396
Pubmed	Aldolase positively regulates of the canonical Wnt signaling pathway.	ALDOA ALDOB ALDOC	2.33e-07	3	215	3	24993527
Pubmed	Human skeletal-muscle aldolase: N-terminal sequence analysis of CNBr- and o-iodosobenzoic acid-cleavage fragments.	ALDOA ALDOB ALDOC	2.33e-07	3	215	3	6696436
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STARD13 MYH6 MYLK ACTBL2 HNRNPM PFKP KRT73 CDCA2 RUNDC3A DST CLCN3 SACS GCLC NIP7 XRN1 KDR SIPA1L2 TASOR DNAH8 KIF13B RANGAP1 ANK2 GRK5 SHB LCP1 CADPS2 SPATA13	3.27e-07	1442	215	27	35575683
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	GBF1 ZNF585A TRIO VWA8 CYTH3 FYCO1 PTCH1 ITGB5 ITPR3 FAT1 DST UBN1 NLRC5 SIPA1L2 TBCD AGAP3 PNPLA2 ZNF48 GRK5 HECTD4 ADAMTS7 MAPKBP1 SPATA13	4.33e-07	1105	215	23	35748872
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	SSPOP ADAMTS15 FGF8 KDR SEMA5A THSD7B ADAMTS7	4.35e-07	75	215	7	20637190
Pubmed	GATA6 is a crucial regulator of Shh in the limb bud.	GATA3 PTCH1 ALX4 DHH FGF8	5.10e-07	26	215	5	24415953
Pubmed	Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis.	PLGLA PLG PLGLB1	9.28e-07	4	215	3	1986355
Pubmed	Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump.	ALDOA ALDOB ALDOC	9.28e-07	4	215	3	11399750
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KDM5B DLG5 GBF1 TRIO HJURP PFKP MEF2D CDCA2 POLR1F DLC1 DST XRN1 SIPA1L2 AGAP3 KIF13B KIF26B HNRNPUL1 DNAH7 SPATA13	1.98e-06	861	215	19	36931259
Pubmed	Interaction between the triglyceride lipase ATGL and the Arf1 activator GBF1.	GBF1 CYTH2 PNPLA2	2.31e-06	5	215	3	21789191
Pubmed	Rewiring of embryonic glucose metabolism via suppression of PFK-1 and aldolase during mouse chorioallantoic branching.	PFKP ALDOA ALDOB ALDOC	4.06e-06	18	215	4	28049690
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	ABCF1 HNRNPM KATNAL1 CMYA5 PFKP ZNF836 AP1G1 ALB ZFP62 AGAP3 CCT7 HNRNPUL1 CBS	5.38e-06	451	215	13	36168627
Pubmed	Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development.	HK3 ACSS1 GCK PFKP ALDOA ALDOB ALDOC	7.35e-06	114	215	7	28245920
Pubmed	Disruption of Scube2 Impairs Endochondral Bone Formation.	PTCH1 DHH SCUBE2	8.01e-06	7	215	3	25639508
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	STARD13 ABCF1 AGO2 PSMB3 HNRNPM PFKP MYEF2 CDCA2 ACSL1 POLR1F DST UBN1 AP1G1 UGDH XRN1 ALDOA METAP2 NXF1 RANGAP1 CCT7 HNRNPUL1 KIF20A SHCBP1	1.25e-05	1353	215	23	29467282
Pubmed	Severe nasal clefting and abnormal embryonic apoptosis in Alx3/Alx4 double mutant mice.	PTCH1 ALX4 FGF8	1.28e-05	8	215	3	11641221
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	TRIO CMYA5 ITGB5 DST CLIC5 UGDH MYO18B ALDOA COL12A1 ANK2 SHB ZNF181 MRFAP1	1.51e-05	497	215	13	23414517
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	FRMPD4 VWA8 SSPOP DST TASOR THSD7B CADPS2	1.74e-05	130	215	7	12421765
Pubmed	The mouse polydactylous mutation, luxate (lx), causes anterior shift of the anteroposterior border in the developing hindlimb bud.	PTCH1 ALX4 FGF8	1.90e-05	9	215	3	12455637
Pubmed	A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis.	GCK PTCH1 ALX4 ALDOA ALDOC	1.94e-05	53	215	5	38466355
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ABCF1 HNRNPM FYCO1 MYEF2 ITPR3 CDCA2 NIP7 NXF1 HECTD4 CCT7 HNRNPUL1 KIF20A	2.14e-05	440	215	12	34244565
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	GBF1 PSMB3 HNRNPM AP1G1 GCLC ALDOC KIF27 OAT HNRNPUL1 LCP1	2.19e-05	304	215	10	32235678
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ABCF1 PSMB3 HNRNPM ZMYM2 PFKP DST XRN1 SIPA1L2 ALDOA ALDOC TASOR RANGAP1 ANK2 CCT7 OAT HNRNPUL1 CBS SMCR8	2.30e-05	934	215	18	33916271
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	DLG5 ACTBL2 HNRNPM DST DNAH8 MXRA5 CIP2A CCT7	2.32e-05	187	215	8	26460568
Pubmed	Targeted misexpression of constitutively active BMP receptor-IB causes bifurcation, duplication, and posterior transformation of digit in mouse limb.	PTCH1 ALX4 FGF8	2.71e-05	10	215	3	10753507
Pubmed	Genetic analysis of the role of Alx4 in the coordination of lower body and external genitalia formation.	PTCH1 ALX4 FGF8	2.71e-05	10	215	3	23942202
Pubmed	Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo.	PTCH1 DHH KDR	2.71e-05	10	215	3	11311154
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYH6 ABCF1 AGO2 TRIO CYTH2 ACTBL2 PSMB3 HNRNPM PFKP MYEF2 DST AP1G1 SACS XRN1 ALB SIPA1L2 ALDOA ALDOC METAP2 AGAP3 ANK2 CCT7 OAT	3.00e-05	1431	215	23	37142655
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	HNRNPM CDCA2 FAT1 DST UGDH XRN1 ALB ALDOA TASOR AGAP3 CCT7 HNRNPUL1 DNAH7 KIF20A SLFN13 SMCR8	3.03e-05	777	215	16	35844135
Pubmed	Serum Inflammation Parameters and Survival in Hepatocellular Carcinoma Patients: Importance of Albumin and Gamma-Glutamyltranspeptidase.	GGT1 ALB	3.80e-05	2	215	2	36878197
Pubmed	KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo.	KDR KIF13B	3.80e-05	2	215	2	34670814
Pubmed	Akt-mediated phosphorylation of argonaute 2 downregulates cleavage and upregulates translational repression of MicroRNA targets.	AGO2 AKT3	3.80e-05	2	215	2	23603119
Pubmed	Structure and expression of mouse aldolase genes. Brain-specific aldolase C amino acid sequence is closely related to aldolase A.	ALDOA ALDOC	3.80e-05	2	215	2	3009179
Pubmed	GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.	GATA3 KDM6A	3.80e-05	2	215	2	31685800
Pubmed	Aldolase-B knockout in mice phenocopies hereditary fructose intolerance in humans.	ALDOA ALDOB	3.80e-05	2	215	2	25637246
Pubmed	Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis.	CD163 CD163L1	3.80e-05	2	215	2	11124526
Pubmed	KIF13B mediates VEGFR2 recycling to modulate vascular permeability.	KDR KIF13B	3.80e-05	2	215	2	36928770
Pubmed	Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.	KDR SCUBE2	3.80e-05	2	215	2	27834687
Pubmed	Identifying Cancer-Relevant Mutations in the DLC START Domain Using Evolutionary and Structure-Function Analyses.	STARD13 DLC1	3.80e-05	2	215	2	33142932
Pubmed	ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression.	CYTH2 KDR	3.80e-05	2	215	2	22002459
Pubmed	De-Ubiquitinating Enzymes USP21 Regulate MAPK1 Expression by Binding to Transcription Factor GATA3 to Regulate Tumor Growth and Cell Stemness of Gastric Cancer.	GATA3 USP21	3.80e-05	2	215	2	33791299
Pubmed	Patched1 haploinsufficiency impairs ependymal cilia function of the quaking viable mice, leading to fatal hydrocephalus.	PTCH1 QKI	3.80e-05	2	215	2	21447392
Pubmed	Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell.	DLG5 KIF20A	3.80e-05	2	215	2	15665285
Pubmed	A developmental study of the Desert hedgehog-null mouse testis.	PTCH1 DHH	3.80e-05	2	215	2	11673255
Pubmed	Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth.	PTCH1 KIF20A	3.80e-05	2	215	2	33976373
Pubmed	Revisiting ankyrin-InsP3 receptor interactions: ankyrin-B associates with the cytoplasmic N-terminus of the InsP3 receptor.	ITPR3 ANK2	3.80e-05	2	215	2	18275062
Pubmed	The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration.	KDR SHB	3.80e-05	2	215	2	15026417
Pubmed	KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2.	KDR KIF13B	3.80e-05	2	215	2	25128562
Pubmed	Structural Organization and Dynamics of Homodimeric Cytohesin Family Arf GTPase Exchange Factors in Solution and on Membranes.	CYTH3 CYTH2	3.80e-05	2	215	2	31601460
Pubmed	Mouse liver protein database: a catalog of proteins detected by two-dimensional gel electrophoresis.	ALB OAT	3.80e-05	2	215	2	1286668
Pubmed	Defining the membrane proteome of NK cells.	ABCF1 AGO2 GBF1 HNRNPM FYCO1 PFKP APOBR ITPR3 ACSL1 AGO4 PIGA CLCN3 AP1G1 XRN1 ALDOA DOCK2 NIBAN1 VPS50 ST3GAL4 ACSL5	4.27e-05	1168	215	20	19946888
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	PDC AGO2 HNRNPM PFKP SYNPR MYEF2 SAG ALB ALDOA USP48 ALDOC CCT7 HNRNPUL1	4.46e-05	552	215	13	36293380
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	STARD13 ABCF1 AGO2 ACTBL2 PSMB3 HNRNPM FYCO1 PFKP MYEF2 DST AP1G1 ALDOA ALDOC DOCK2 CCT7 HNRNPUL1	4.74e-05	807	215	16	30575818
Pubmed	The molecular basis of Pallister Hall associated polydactyly.	PTCH1 ALX4 FGF8	4.92e-05	12	215	3	17588959
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	STARD13 ZFP3 FYCO1 HENMT1 FAT1 DLC1 DST CLIC5 CLCN3 KDR FASTKD3 USP48 SLC26A3 COL12A1 ST3GAL4 DNAH7 MRFAP1 SHCBP1 CADPS2 SMCR8 SPATA13	5.83e-05	1293	215	21	15342556
Pubmed	Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development.	PTCH1 ALX4 FGF8	6.37e-05	13	215	3	25448692
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	ABCF1 ACTBL2 MYEF2 DST SACS UGDH XRN1 NXF1 TBCD RANGAP1 CIP2A VPS50	7.06e-05	498	215	12	36634849
Pubmed	Genetic interaction between Gli3 and Ezh2 during limb pattern formation.	ALX4 DHH FGF8	8.06e-05	14	215	3	29729398
Pubmed	Sufu and Kif7 in limb patterning and development.	PTCH1 ALX4 FGF8	8.06e-05	14	215	3	25581370
Pubmed	Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins.	FGF8 MAFB COL12A1	8.06e-05	14	215	3	28511701
Pubmed	A long non-coding RNA specifically expressed in early embryos programs the metabolic balance in adult mice.	PFKP ALDOA ALDOC PNPLA2	9.86e-05	39	215	4	33059001
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	TRIO AP1G1 SACS UFSP1 AGAP3 VPS50 HNRNPUL1 ATG3	9.95e-05	230	215	8	35449600
Pubmed	Conditional inactivation of Fgfr1 in mouse defines its role in limb bud establishment, outgrowth and digit patterning.	PTCH1 ALX4 FGF8	1.00e-04	15	215	3	16120640
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	ABCF1 GBF1 ACTBL2 PSMB3 HNRNPM CMYA5 PFKP AP1G1 GCLC UGDH ALDOA USP48 ALDOC METAP2 TBCD CARM1 NIBAN1 RANGAP1 CCT7 HNRNPUL1 CBS ATG3	1.09e-04	1455	215	22	22863883
Pubmed	Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint.	KATNAL1 DLC1 COL12A1 GRIK3 NECTIN3 ZCCHC3	1.11e-04	121	215	6	26354767
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	AGO2 TRIO CYTH3 CYTH2 HNRNPM ZMYM2 FYCO1 MYEF2 DST CARM1 KIF13B RANGAP1 ANK2 HECTD4 GRIK3 GRM4 SPATA13	1.13e-04	963	215	17	28671696
Pubmed	Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1.	GATA3 MAFB	1.14e-04	3	215	2	25917456
Pubmed	Highly oxidized albumin is cleared by liver sinusoidal endothelial cells via the receptors stabilin-1 and -2.	ALB STAB2	1.14e-04	3	215	2	37926735
Pubmed	Regulating ankyrin dynamics: Roles of sigma-1 receptors.	ITPR3 ANK2	1.14e-04	3	215	2	11149946
Pubmed	Differential regulation of γ-glutamyltransferase and glutamate cysteine ligase expression after mitochondrial uncoupling: γ-glutamyltransferase is regulated in an Nrf2- and NFκB-independent manner.	GGT1 GCLC	1.14e-04	3	215	2	23448276
Pubmed	Structural basis and mechanism of autoregulation in 3-phosphoinositide-dependent Grp1 family Arf GTPase exchange factors.	CYTH3 CYTH2	1.14e-04	3	215	2	18042453
Pubmed	Genetic analysis of mouse t haplotypes using mutations induced by ethylnitrosourea mutagenesis: the order of T and qk is inverted in t mutants.	ITPR3 QKI	1.14e-04	3	215	2	3197958
Pubmed	Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules.	PTCH1 DHH	1.14e-04	3	215	2	11090455
Pubmed	Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.	ACSL1 ACSL5	1.14e-04	3	215	2	28498416
Pubmed	Rab18 regulates lipolysis via Arf/GBF1 and adipose triglyceride lipase.	GBF1 PNPLA2	1.14e-04	3	215	2	31610914
Pubmed	Oxidized low density lipoprotein impairs endothelial progenitor cell function by downregulation of E-selectin and integrin alpha(v)beta5.	ITGB5 SELE	1.14e-04	3	215	2	18590706
Pubmed	Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins.	AGO2 AGO4	1.14e-04	3	215	2	19946268
Pubmed	Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis.	STARD13 DLC1	1.14e-04	3	215	2	20600027
Pubmed	Expression of Patched-1 and Smoothened in testicular meiotic and post-meiotic cells.	PTCH1 DHH	1.14e-04	3	215	2	19484749
Pubmed	Cross talk between engulfment receptors stabilin-2 and integrin αvβ5 orchestrates engulfment of phosphatidylserine-exposed erythrocytes.	ITGB5 STAB2	1.14e-04	3	215	2	22566688
Pubmed	Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.	KDR AKT3	1.14e-04	3	215	2	25501707
Pubmed	Development of murine hepatic sinusoidal endothelial cells characterized by the expression of hyaluronan receptors.	KDR STAB2	1.14e-04	3	215	2	17626278
Pubmed	Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation.	GATA3 USP21	1.14e-04	3	215	2	25680095
Pubmed	Hedgehog signaling via its ligand DHH acts as cell fate determinant during skeletal muscle regeneration.	PTCH1 DHH	1.14e-04	3	215	2	37355632
Pubmed	HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment.	KDR ALB	1.14e-04	3	215	2	11145723
Pubmed	Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.	KDM5B GATA3	1.14e-04	3	215	2	24802759
Pubmed	Identification of the E3 deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a positive regulator of the transcription factor GATA3.	GATA3 USP21	1.14e-04	3	215	2	23395819
Pubmed	Pax2 regulates neuronal-glial cell fate choice in the embryonic optic nerve.	PTCH1 FGF8	1.14e-04	3	215	2	17173889
Pubmed	Phospholipase D2 directly interacts with aldolase via Its PH domain.	ALDOA ALDOC	1.14e-04	3	215	2	11876650
Pubmed	Phosphoinositide specificity determines which cytohesins regulate β1 integrin recycling.	CYTH3 CYTH2	1.14e-04	3	215	2	22454518
Pubmed	Complex regulation of multiple cytohesin-like genes in murine tissues and cells.	CYTH3 CYTH2	1.14e-04	3	215	2	9744817
Pubmed	Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb.	PTCH1 ALX4 FGF8	1.23e-04	16	215	3	21795281
Pubmed	Bmp4 in limb bud mesoderm regulates digit pattern by controlling AER development.	PTCH1 ALX4 FGF8	1.23e-04	16	215	3	15581864
Pubmed	A switch from low to high Shh activity regulates establishment of limb progenitors and signaling centers.	PTCH1 ALX4 FGF8	1.23e-04	16	215	3	24726283
Pubmed	Aristaless related homeobox gene, Arx, is implicated in mouse fetal Leydig cell differentiation possibly through expressing in the progenitor cells.	PTCH1 DHH MAFB	1.23e-04	16	215	3	23840809
Pubmed	Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.	ACSS1 HJURP ITGB5 MAFB QKI ALDOC PDE11A CBS CADPS2 SPATA13	1.28e-04	376	215	10	24154525
Cytoband	19q13.12	ZNF585A ZNF829 ZNF790 ZNF420 ZNF565	2.33e-05	72	215	5	19q13.12
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	CABP5 ZNF585A ZNF274 CYTH2 ZNF829 ZNF836 ZNF324 ZNF329 IRGQ HNRNPUL1 FAM90A27P ZNF181 ITPKC ZNF790 ZNF420 ZNF565	1.76e-04	1192	215	16	chr19q13
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF585A ZNF274 ZFP3 ZNF829 ZNF836 ZNF324 ZNF770 ZFP62 ZNF48 ZNF329 ZNF181 GZF1 ZNF197 ZNF790 ZNF420 ZFP92 ZNF565 ZNF44	1.65e-05	718	144	18	28
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF13B KIF27 KIF26B KIF20A	4.86e-04	46	144	4	622
GeneFamily	Acyl-CoA synthetase family	ACSS1 ACSL1 ACSL5	1.12e-03	26	144	3	40
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	CD163 CD163L1 STAB2	1.26e-03	27	144	3	1253
GeneFamily	Argonaute/PIWI family	AGO2 AGO4	1.71e-03	8	144	2	408
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYLK TRIO KDR SDK2 MXRA5 NECTIN3	1.84e-03	161	144	6	593
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL	MATN2 ACSL1 RUNDC3A DST MAFB RAB26 COL12A1 ANK2 RUNX1T1 GPC6	5.99e-07	155	213	10	M45695
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	STARD13 DLG5 GBF1 TRIO NRN1 CDCA2 POLR1F FAT1 SACS ATAD2B XRN1 ADAMTS15 FGF8 MYO18B QKI TBCD SDK2 ANK2 SHB OAT ST3GAL4 ZNF420 SPATA13	8.80e-06	1009	213	23	M157
Coexpression	MURARO_PANCREAS_BETA_CELL	KATNAL1 PTCH1 ZC3H6 ITPR3 DST PIGA CLCN3 UBN1 ZNF770 MAFB SIPA1L2 USP48 ALDOC FNIP2 AKT3 HECTD4 SEMA5A CASR NECTIN3 RUNX1T1 ATG3 GPSM1	1.02e-05	946	213	22	M39169
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP	PFKP NLRC5 CARM1 NIBAN1 RANGAP1 ACSL5 SPATA13	1.19e-05	94	213	7	M40880
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	DLG5 CYTH3 MATN2 PFKP ACSL1 RUNDC3A DST RAB26 AKT3 COL12A1 ANK2 RUNX1T1 GPC6 MAPKBP1	1.23e-05	429	213	14	M45694
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	MATN2 NRN1 ACSL1 PLG C9 KIF13B STAB2 PON3 LCP1 CBS	1.67e-05	225	213	10	M6175
Coexpression	NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	ZNF585A ZNF829 ZNF790 ZNF420	2.76e-05	22	213	4	M8692
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	MATN2 NRN1 ACSL1 PLG C9 KIF13B STAB2 PON3 LCP1 CBS	2.80e-05	239	213	10	MM1274
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	ZNF274 HIPK1 HNRNPM GATA3 ZMYM2 POLR1F PIGA AP1G1 ATAD2B USP48 KDM6A AKT3 PPM1K SMCR8	3.68e-05	474	213	14	M40991
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	HIPK1 SAG AGO4 ARHGAP31 ATAD2B QKI AGAP3 ITPKC SMCR8	3.87e-05	199	213	9	M9501
Coexpression	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN	AGO2 HNRNPM ACSL1 MAFB COL16A1 OAT ITPKC SHCBP1 ACSL5	3.87e-05	199	213	9	M9970
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	KDM5B AGO2 TRIO GCK ZC3H6 C9 PDE11A HECTD4 SLFN13	3.87e-05	199	213	9	M7448
Coexpression	GSE27786_LSK_VS_ERYTHROBLAST_DN	ACSS1 MYEF2 METAP2 RAB26 PDE11A SELE ST3GAL4 NECTIN3 ECHDC2	4.02e-05	200	213	9	M4759
Coexpression	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	DLG5 CYTH3 FYCO1 KATNAL1 AGO4 NIBAN1 ST3GAL4 LCP1 SLFN13	4.02e-05	200	213	9	M6513
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	CMYA5 FAT1 DST CLIC5 QKI AKT3 SEMA5A GPC6 CR1	6.32e-05	212	213	9	M39221
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	FILIP1 SYNPO2 MYLK TRIO COLCA1 ZC3H6 DLC1 DST ADAMTS15 CPLANE1 METAP2 AKT3 NIBAN1 KIF26B SEMA5A RUNX1T1 GPC6	6.14e-07	408	208	17	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_100	FILIP1 SYNPO2 CD163 NIBAN1	4.16e-06	12	208	4	gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	FILIP1 SYNPO2 MYLK PTCH1 ZC3H6 ABCA9 MYEF2 CDCA2 DLC1 PIGA UGDH ADAMTS15 ZNF770 CPLANE1 AKT3 NIBAN1 CIP2A SEMA5A THSD7B RUNX1T1 ZNF420 SPATA13	2.17e-05	826	208	22	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	FILIP1 SYNPO2 MYLK TRIO VWA8 GATA3 PTCH1 NRN1 ZC3H6 DST CLCN3 ADAMTS15 CPLANE1 AKT3 NIBAN1 KIF26B SEMA5A RUNX1T1 GPC6 ADAMTS7 ZNF565	4.63e-05	806	208	21	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	FILIP1 SYNPO2 MYLK GATA3 ZC3H6 DST ADAMTS15 CPLANE1 AKT3 NIBAN1 KIF26B SEMA5A RUNX1T1 GPC6	5.19e-05	407	208	14	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500	FILIP1 SYNPO2 MYLK ZC3H6 CDCA2 DLC1 ADAMTS15 ZNF770 AKT3 NIBAN1 SEMA5A THSD7B RUNX1T1 ZNF420	7.64e-05	422	208	14	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	DLG5 SYNPO2 CYTH3 FYCO1 ITGB5 ATAD2B MAFB NIBAN1 SDK2 KIF26B PRSS12 SEMA5A OAT RUNX1T1 RAB36 ZFP92 ECHDC2	8.55e-05	596	208	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500	FILIP1 SYNPO2 MYLK GATA3 PFKP NRN1 ABCA9 CD163 DST CLIC5 NLRC5 NIBAN1 SCUBE2	9.65e-05	378	208	13	gudmap_developingLowerUrinaryTract_adult_bladder_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	DLG5 SYNPO2 VWA8 CYTH3 ITGB5 ATAD2B MAFB NIBAN1 SDK2 KIF26B HECTD4 SEMA5A OAT RUNX1T1 RAB36 ZFP92 ECHDC2	1.07e-04	607	208	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	TRIO COLCA1 ZC3H6 DLC1 CPLANE1 METAP2 AKT3 SEMA5A GPC6	1.30e-04	194	208	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_500	FILIP1 MYH6 SYNPO2 MYLK MATN2 ZC3H6 ABCA9 CD163 DLC1 DST ALDOB SEMA5A SCUBE2	1.32e-04	390	208	13	gudmap_developingLowerUrinaryTract_P1_ureter_500
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_1000	SYNPO2 MYLK VWA8 MATN2 GGT1 CLIC5 ADAMTS15 ALB CPLANE1 ALDOB TASOR AKT3 KIF26B PCDHB9 SEMA5A GPC6 SCUBE2 ZNF790 ZNF565 CADPS2	1.44e-04	809	208	20	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_500	MYH6 MATN2 ZC3H6 DLC1 ALDOB SEMA5A	1.45e-04	81	208	6	gudmap_developingLowerUrinaryTract_P1_ureter_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_200	FILIP1 SYNPO2 MYLK NRN1 CD163 NLRC5 NIBAN1 SCUBE2	1.85e-04	160	208	8	gudmap_developingLowerUrinaryTract_adult_bladder_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100	FILIP1 SYNPO2 MYLK CD163 DST NIBAN1	2.01e-04	86	208	6	gudmap_developingLowerUrinaryTract_P1_bladder_100_J
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1	DLG5 SYNPO2 ZNF274 CYTH3 FYCO1 ITGB5 ALX4 MAFB NIBAN1 SDK2 KIF26B SEMA5A OAT RUNX1T1 RAB36 ZFP92	2.40e-04	589	208	16	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2	DLG5 SYNPO2 VWA8 CYTH3 FYCO1 ITGB5 CLIC5 MAFB NIBAN1 SDK2 KIF26B HECTD4 SEMA5A OAT RUNX1T1 RAB36 ZFP92	2.62e-04	655	208	17	Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	SYNPO2 TRIO ZC3H6 DST AKT3 NIBAN1 KIF26B SEMA5A	2.80e-04	170	208	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	AGO2 MYLK TRIO MATN2 HJURP CDCA2 ARHGAP31 KDR CPLANE1 KDM6A SDK2 COL16A1 PCDHB9 SEMA5A SRR PPM1K RUNX1T1 GPC6 ZNF420	2.98e-04	790	208	19	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	AGO2 MYLK TRIO MATN2 HJURP GGT1 ARHGAP31 KDR CPLANE1 KDM6A SLC26A3 COL12A1 COL16A1 PCDHB9 SEMA5A PPM1K RUNX1T1 GPC6 ZNF420	3.43e-04	799	208	19	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_200	FILIP1 SYNPO2 CD163 NIBAN1	3.69e-04	35	208	4	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	FILIP1 SYNPO2 MYLK TRIO GATA3 COLCA1 ZC3H6 DLC1 DST ADAMTS15 CPLANE1 METAP2 AKT3 NIBAN1 KIF26B SEMA5A RUNX1T1 GPC6 USP21	3.82e-04	806	208	19	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#5_top-relative-expression-ranked_1000	NRN1 ABCA9 CD163 CLIC5 NLRC5 ARRDC4 CLDN10	3.93e-04	136	208	7	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k5
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3	KDM5B TRIO CYTH3 GATA3 MEF2D GGT1 ITPR3 NLRC5 DNAH8 NLRC3 SLFN13 SPATA13	4.08e-04	382	208	12	GSM476684_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000	FILIP1 SYNPO2 MYLK HJURP NRN1 ZC3H6 MYEF2 DLC1 ADAMTS15 ZNF770 CPLANE1 METAP2 AKT3 NIBAN1 SEMA5A THSD7B RUNX1T1 GPC6 SPATA13	4.12e-04	811	208	19	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	ABCF1 ZFP3 ACSS1 ZMYM2 PTCH1 MYEF2 CDCA2 FAT1 RUNDC3A CPLANE1 QKI KDM6A DNASE1L1 MOK AKT3 GARNL3 ZNF48 ANK2 CIP2A ZNF329 NECTIN3 IRGQ HNRNPUL1 GRM4 ADAMTS7 CADPS2 SPATA13	4.16e-04	1370	208	27	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2	VWA8 ACSS1 HJURP FAT1 DST CLIC5 SIPA1L2 DNASE1L1 NXF1 AKT3 GARNL3 ANK2 HECTD4 SRR IRGQ GPC6 ADAMTS7 MAPKBP1	4.22e-04	747	208	18	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CABP5 CMYA5 RAB26 SDK2 COL12A1 COL16A1 GARNL3 PRSS12 SEMA5A GRIK3 THSD7B CLDN10	1.30e-11	154	214	12	12cbc38bc1f7231c67e1d2d5e86e95bc12e24682
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CABP5 CMYA5 RAB26 SDK2 COL12A1 COL16A1 GARNL3 SEMA5A GRIK3 THSD7B CLDN10	2.77e-10	156	214	11	fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	FILIP1 MYH6 SYNPO2 VWA8 CMYA5 DST MYO18B QKI NIBAN1 ANK2 GPSM1	2.25e-09	190	214	11	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 RAB26 SDK2 SHB SEMA5A GRIK3 GRM4 CADPS2	1.54e-08	177	214	10	4c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 RAB26 SDK2 SHB SEMA5A GRIK3 GRM4 CADPS2	1.91e-08	181	214	10	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 RAB26 SDK2 COL12A1 SHB SEMA5A GRIK3 GRM4	2.12e-08	183	214	10	65f2a5895d166189a095cf7ea9dda171f0419b08
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CMYA5 DST CLIC5 MAFB WDR49 ARRDC4 GRK5 SEMA5A CR1 GPSM1	2.35e-08	185	214	10	9197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CMYA5 DST CLIC5 MAFB WDR49 ARRDC4 GRK5 SEMA5A CR1 GPSM1	2.35e-08	185	214	10	ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DLG5 SYNPO2 CLIC5 SELE SDK2 COL12A1 PRSS12 SHB GRIK3	2.69e-08	140	214	9	17005ca714ba03d7528fe7979ffb4654a46b666c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MATN2 PTCH1 ABCA9 DLC1 DNAH8 COL16A1 GRK5 RUNX1T1	2.88e-08	189	214	10	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MATN2 PTCH1 ABCA9 DLC1 DNAH8 COL16A1 GRK5 RUNX1T1	2.88e-08	189	214	10	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 CYTH3 MATN2 ABCA9 DLC1 COL12A1 COL16A1 KIF26B RUNX1T1	3.18e-08	191	214	10	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	FILIP1 MYH6 SYNPO2 VWA8 CMYA5 DST MYO18B QKI NIBAN1 ANK2	3.18e-08	191	214	10	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 CYTH3 MATN2 ABCA9 DLC1 COL12A1 COL16A1 KIF26B RUNX1T1	3.18e-08	191	214	10	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK DLC1 NIBAN1 GRK5 SEMA5A THSD7B RUNX1T1 GPC6	3.34e-08	192	214	10	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLG5 COLCA1 NRN1 DLC1 KDR MOK AKT3 SDK2 GZF1 SHCBP1	3.87e-08	195	214	10	6a0460d949ccda7c9fe76870d3ee6c2f60677d61
ToppCell	background-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	FILIP1 ABCA9 ARHGAP31 KDR ALB ALDOB AKT3 SLC26A3 STAB2 RUNX1T1	3.87e-08	195	214	10	c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 MATN2 PTCH1 ABCA9 DLC1 COL12A1 COL16A1 KIF26B GRK5 RUNX1T1	3.87e-08	195	214	10	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 DLC1 NIBAN1 COL16A1 GRK5 RUNX1T1 GPC6	4.06e-08	196	214	10	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 ABCA9 DLC1 COL12A1 COL16A1 GRK5 RUNX1T1	4.06e-08	196	214	10	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 DLC1 NIBAN1 COL16A1 GRK5 RUNX1T1 GPC6	4.06e-08	196	214	10	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	nucseq-Immune-Immune_Myeloid-IM\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	STARD13 CD163 ACSL1 CD163L1 MAFB C9 AGAP3 FNIP2 DOCK2 CR1	4.26e-08	197	214	10	6f41c8f815851968849428ec92c16745bd01a3fb
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 ABCA9 DLC1 COL12A1 COL16A1 GRK5 RUNX1T1	4.26e-08	197	214	10	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	nucseq-Immune-Immune_Myeloid-IM-IM\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	STARD13 CD163 ACSL1 CD163L1 MAFB C9 AGAP3 FNIP2 DOCK2 CR1	4.26e-08	197	214	10	304044ace926943b8eb588f686ecbe5d1689a809
ToppCell	Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	FRMPD4 GCK FAT1 RUNDC3A SAG DST ZFP62 PDE11A GARNL3 GRIK3	4.47e-08	198	214	10	dcf334d13e5b0018fee24febccfef91c9e17843b
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYLK PTCH1 DST ADAMTS15 SDK2 COL16A1 ANK2 PRSS12 SEMA5A SPATA13	4.69e-08	199	214	10	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SYNPO2 MYLK MATN2 PTCH1 DST MXRA5 COL12A1 ANK2 RUNX1T1 GPC6	4.69e-08	199	214	10	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CMYA5 RAB26 SDK2 COL12A1 GARNL3 SHB GRIK3 THSD7B CLDN10	5.18e-08	151	214	9	f50c5ae9dae507df750df25e151b58685fec70ce
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CMYA5 DST CLIC5 MAFB WDR49 GRK5 SEMA5A CR1 GPSM1	1.29e-07	168	214	9	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DLG5 SYNPO2 CLIC5 SELE SDK2 COL12A1 PRSS12 SHB	1.39e-07	122	214	8	dba1c647172a11381efcb178a23808161908daa3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 DLC1 SIPA1L2 NIBAN1 GRK5 SEMA5A THSD7B RUNX1T1	2.02e-07	177	214	9	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 RAB26 SDK2 SEMA5A GRIK3 GRM4 CADPS2	2.02e-07	177	214	9	bde307e67ad8e48a5ff4c0827015f4688f6b3e46
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 DLC1 SIPA1L2 NIBAN1 GRK5 SEMA5A THSD7B RUNX1T1	2.02e-07	177	214	9	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MATN2 PTCH1 ABCA9 DLC1 COL12A1 COL16A1 RUNX1T1	2.12e-07	178	214	9	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 RAB26 SDK2 SEMA5A GRIK3 GRM4 CADPS2	2.22e-07	179	214	9	7954c0026754ab869b88ab7feb13c2f27d6e272d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 RAB26 SDK2 SHB SEMA5A GRIK3 GRM4	2.22e-07	179	214	9	f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac\|lymph-node_spleen / Manually curated celltypes from each tissue	STARD13 HK3 HJURP CD163 CDCA2 CD163L1 MAFB KIF20A SHCBP1	2.33e-07	180	214	9	4eea8366cdb82c356325ce88f09ad8b302c17a07
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 RAB26 SDK2 SEMA5A GRIK3 GRM4 CADPS2	2.33e-07	180	214	9	b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DLG5 CLIC5 SDK2 PRSS12 SHB THSD7B TG SCUBE2	2.41e-07	131	214	8	81efe8b0ca4377e557a42ddb12aecaf3f46b15bf
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNPO2 MYLK PTCH1 DST ADAMTS15 SDK2 COL12A1 COL16A1 GPC6	2.44e-07	181	214	9	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CMYA5 CLIC5 MAFB WDR49 ARRDC4 GRK5 SEMA5A CR1 GPSM1	2.68e-07	183	214	9	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK DLC1 NIBAN1 COL12A1 GRK5 SEMA5A RUNX1T1	2.68e-07	183	214	9	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DST CLIC5 MAFB WDR49 ARRDC4 GRK5 SEMA5A CR1 GPSM1	2.93e-07	185	214	9	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic\|bone_marrow / Manually curated celltypes from each tissue	ABHD12B HJURP CDCA2 DST WDR49 SDK2 CIP2A KIF20A SHCBP1	2.93e-07	185	214	9	9d3168c7f0b1d739f78b368969cf5c77ce202b97
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	METAP1D ITGB5 SYNPR MAFB QKI KIF26B GRIK3 RUNX1T1 GPC6	3.21e-07	187	214	9	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	FILIP1 CMYA5 FAT1 CLIC5 MYO18B QKI FNIP2 NIBAN1 ANK2	3.67e-07	190	214	9	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 MYH6 SYNPO2 CMYA5 DLC1 CLIC5 MYO18B NIBAN1 ANK2	3.67e-07	190	214	9	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MATN2 ABCA9 DLC1 COL12A1 COL16A1 GRK5 RUNX1T1	4.01e-07	192	214	9	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK PTCH1 ITGB5 FAT1 MXRA5 COL12A1 KIF26B RUNX1T1 GPC6	4.01e-07	192	214	9	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK ABCA9 DLC1 COL12A1 COL16A1 GRK5 RUNX1T1	4.19e-07	193	214	9	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SYNPO2 MYLK PTCH1 FAT1 DST MXRA5 COL12A1 SEMA5A RUNX1T1	4.19e-07	193	214	9	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK ABCA9 DLC1 DST ADAMTS15 GRK5 RUNX1T1 GPC6 GPSM1	4.19e-07	193	214	9	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNPO2 MYLK PTCH1 ITGB5 FAT1 MXRA5 COL12A1 KIF26B GPC6	4.19e-07	193	214	9	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	FILIP1 MYH6 CMYA5 SYNPR CLIC5 MYO18B WDR49 NIBAN1 ANK2	4.38e-07	194	214	9	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 ABCA9 DLC1 DST GRK5 RUNX1T1	4.38e-07	194	214	9	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 ABCA9 DLC1 DST GRK5 RUNX1T1	4.38e-07	194	214	9	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRMPD4 MYLK ADAMTS15 SDK2 COL16A1 ANK2 KIF26B SEMA5A RUNX1T1	4.38e-07	194	214	9	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	MYLK ABCA9 DST MXRA5 COL16A1 ANK2 KIF26B RUNX1T1 GPC6	4.38e-07	194	214	9	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MATN2 PTCH1 ABCA9 DLC1 COL12A1 COL16A1 RUNX1T1	4.38e-07	194	214	9	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK DLC1 NIBAN1 COL12A1 COL16A1 RUNX1T1 GPC6	4.38e-07	194	214	9	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 DLC1 COL12A1 COL16A1 GRK5 RUNX1T1	4.57e-07	195	214	9	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK CYTH3 MATN2 ABCA9 DLC1 COL12A1 COL16A1	4.57e-07	195	214	9	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK MATN2 DLC1 COL12A1 COL16A1 GRK5 RUNX1T1	4.57e-07	195	214	9	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK CYTH3 MATN2 ABCA9 DLC1 COL12A1 COL16A1	4.57e-07	195	214	9	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK ABCA9 DLC1 DST ADAMTS15 COL16A1 GRK5 RUNX1T1 GPC6	4.77e-07	196	214	9	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK CYTH3 MATN2 DLC1 COL12A1 COL16A1 RUNX1T1	4.77e-07	196	214	9	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SYNPO2 MYLK CYTH3 MATN2 DLC1 COL12A1 COL16A1 RUNX1T1	4.77e-07	196	214	9	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 MATN2 PTCH1 ABCA9 COL12A1 COL16A1 KIF26B GRK5 RUNX1T1	4.98e-07	197	214	9	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HK3 CLEC5A APOBR CD163 ACSL1 MAFB DOCK2 LCP1 CR1	5.19e-07	198	214	9	ab70bf89690410221ec7aa3149bb50ac34433f99
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	CYTH3 MATN2 ITGB5 FAT1 UGDH MXRA5 COL12A1 COL16A1 ANK2	5.19e-07	198	214	9	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK PTCH1 DST ADAMTS15 SDK2 COL16A1 ANK2 PRSS12 SEMA5A	5.42e-07	199	214	9	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK DST ADAMTS15 SDK2 MXRA5 COL16A1 ANK2 SEMA5A SPATA13	5.42e-07	199	214	9	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	FILIP1 SYNPO2 ABCA9 DLC1 DST COL12A1 COL16A1 GRK5 RUNX1T1	5.42e-07	199	214	9	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	COPD-Myeloid-Macrophage\|COPD / Disease state, Lineage and Cell class	STARD13 CD163 ACSL1 CD163L1 MAFB C9 QKI AGAP3 FNIP2	5.42e-07	199	214	9	4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HK3 CLEC5A CD163 ACSL1 MAFB FNIP2 DOCK2 LCP1 ATG3	5.42e-07	199	214	9	d3f77acb36ac7c56a47ca98b695f46ae5b9ecd12
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 CYP4B1 MATN2 ABCA9 DLC1 COL12A1 ANK2 RUNX1T1 GPC6	5.42e-07	199	214	9	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 CYP4B1 MATN2 ABCA9 CLIC5 COL12A1 ANK2 RUNX1T1 GPC6	5.42e-07	199	214	9	9c2db0bb94cba71a3cc1827844da090e213e0258
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK PTCH1 DST ADAMTS15 COL16A1 ANK2 KIF26B SEMA5A SCUBE2	5.65e-07	200	214	9	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA9 DLC1 KDR AKT3 COL12A1 COL16A1 ANK2 RUNX1T1 GPC6	5.65e-07	200	214	9	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Sigmoid-Dendritic_cell-cycling_DCs\|Dendritic_cell / Region, Cell class and subclass	CLEC5A HJURP ITGB5 CD163 CD163L1 MAFB AGAP3 CR1 SHCBP1	5.65e-07	200	214	9	372fe9018481a4e9ac6ab3af43705a48238c4376
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 PTCH1 SIPA1L2 PDE11A MXRA5 COL12A1 COL16A1 RUNX1T1 GPC6	5.65e-07	200	214	9	3dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 PTCH1 SIPA1L2 PDE11A MXRA5 COL12A1 COL16A1 SEMA5A GPC6	5.65e-07	200	214	9	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	(52)_cycling_DCs\|World / shred on Cell_type and subtype	CLEC5A HJURP ITGB5 CD163 CDCA2 MAFB KIF20A SHCBP1 ARPIN	5.89e-07	201	214	9	ad2d25d84345fdd593065516a05c5c2b5429eac0
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 CLEC5A SYNPR CD163 COL12A1 KIF27 LCP1 SMCR8	1.21e-06	162	214	8	71d7849108a1b59beff40e46000172c45a2f5439
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CMYA5 DLC1 RAB26 SDK2 GARNL3 SHB GRIK3 THSD7B	1.21e-06	162	214	8	58da6bc04cdac0002b0e6a751c96ff95e1a7f70f
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CMYA5 DLC1 RAB26 SDK2 GARNL3 SHB GRIK3 THSD7B	1.21e-06	162	214	8	4d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CMYA5 ARHGAP31 RAB26 COL16A1 GARNL3 SHB GRIK3 THSD7B	1.27e-06	163	214	8	b0aa4a620bd58011225b42ea6dda04e3101ba342
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CABP5 GCK DLC1 NIBAN1 GRK5 SEMA5A THSD7B RUNX1T1	1.39e-06	165	214	8	cd8de98af8a1a8a6c81d71fae807cc07f319f4c9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CABP5 GCK DLC1 NIBAN1 GRK5 SEMA5A THSD7B RUNX1T1	1.39e-06	165	214	8	4f83ac71efc57be3668d8db1e62bad05dc6a5e2b
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STARD13 MATN2 NRN1 DLC1 DST SIPA1L2 ANK2 GRIK3	1.59e-06	168	214	8	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 SDK2 SHB SEMA5A GRIK3 GRM4	1.59e-06	168	214	8	7abaddbcc55e44653d54aa15464266aa6bd5c9d2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CMYA5 DST CLIC5 MAFB WDR49 SEMA5A CR1 GPSM1	1.59e-06	168	214	8	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 SDK2 GARNL3 SHB SEMA5A GRIK3	1.74e-06	170	214	8	417b77c12a7982b1ce4b4bc57f30335d261220f5
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	CLEC5A CMYA5 CD163 CD163L1 MYO18B DOCK2 LCP1 TG	1.74e-06	170	214	8	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CLIC5 SDK2 COL12A1 PRSS12 SHB THSD7B SPATA13	1.88e-06	120	214	7	2b7596946f9268c4202348adf3069decd8313bb0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLIC5 MAFB WDR49 GRK5 SEMA5A GPC6 CR1 GPSM1	1.90e-06	172	214	8	381ae1c3c07d0a424f43455ec571653b192a946a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HJURP CD163 CDCA2 ACSL1 DOCK2 NIBAN1 LCP1 CR1	1.90e-06	172	214	8	ef33b5e0515c6d29fb6d9a673011c1b68ef264f3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLIC5 MAFB WDR49 GRK5 SEMA5A GPC6 CR1 GPSM1	2.07e-06	174	214	8	dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CABP5 CMYA5 RAB26 SDK2 SHB GRIK3 THSD7B	2.10e-06	122	214	7	37612ad087d9c11d4a3466244ab36224de31930b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FILIP1 SYNPO2 DLC1 SDK2 SHB SEMA5A GRIK3 GRM4	2.16e-06	175	214	8	90e29945aa861082c94bb4f331161adc3a6ef899
Computational	Genes in the cancer module 471.	ACSL1 GCLC CBS	1.50e-04	10	119	3	MODULE_471
Computational	Genes in the cancer module 528.	ACSL1 GCLC CBS	2.05e-04	11	119	3	MODULE_528
Computational	Genes upregulated in subsets of cells of a given type within various tumors	TRIO FAT1 DST MXRA5 COL12A1	2.18e-04	50	119	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Drug	0 Gz	PDC ALDOA ALDOB ALDOC	1.10e-07	6	213	4	CID000000372
Drug	chloroacetol phosphate	UGDH ALDOA ALDOB ALDOC	1.10e-07	6	213	4	CID000168137
Drug	acetol phosphate	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000150865
Drug	4-hydroxy-9-fluorenone	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000016139
Drug	Htfp	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000125055
Drug	DIDIT	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000196082
Drug	2-keto-3-deoxy- l-lyxonate	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000192781
Drug	androisoxazole	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000009676
Drug	2-keto-3-bromobutyrate	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000191968
Drug	3-isochromanone	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000078092
Drug	5-deoxy-5-fluoro-L-sorbose	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000191809
Drug	D-ribulose-1-p	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000000615
Drug	4-hydroxy-2-ketopimelate	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000000553
Drug	AC1L19F1	ALDOA ALDOB ALDOC	8.07e-07	3	213	3	CID000000519
Drug	3-phosphoglycerate	HK3 GCK PFKP LDHD PLG ALDOA ALDOB ALDOC SRR	1.29e-06	114	213	9	CID000000724
Drug	alpha-ketobutyrate	PDC LDHD ALDOA ALDOB ALDOC SRR CBS	2.25e-06	64	213	7	CID000000058
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; HL60; HG-U133A	HIPK1 GATA3 MEF2D RUNDC3A ATAD2B TASOR GRK5 CR1 ATP8B2 ITPKC MAPKBP1	2.79e-06	198	213	11	1426_UP
Drug	formylacetate	ALDOA ALDOB ALDOC	3.21e-06	4	213	3	CID000075269
Drug	dihydroxyacetone sulfate	ALDOA ALDOB ALDOC	3.21e-06	4	213	3	CID000439751
Drug	C06441	ALDOA ALDOB ALDOC	3.21e-06	4	213	3	CID000441020
Drug	3-hydroxy-1-indanone	ALDOA ALDOB ALDOC	3.21e-06	4	213	3	CID000176448
Drug	l-123	ALDOA ALDOB ALDOC	3.21e-06	4	213	3	CID000093552
Drug	KT 5926	MYLK SELE LCP1	3.21e-06	4	213	3	ctd:C063769
Drug	DHMP	DST ALDOA ALDOC	3.21e-06	4	213	3	CID000098784
Drug	phosphoenolpyruvate	HK3 ACSS1 GCK PFKP LDHD SACS PLGLB1 ALDOA ALDOB ALDOC CBS	4.92e-06	210	213	11	CID000001005
Drug	glucitol-6-phosphate	HK3 GCK LDHD UGDH ALDOA ALDOC	6.25e-06	49	213	6	CID000000618
Drug	1-o-phosphonohex-2-ulose	GCK PFKP ALDOA ALDOB ALDOC	6.76e-06	29	213	5	CID000000481
Drug	azo dye	ALB ALDOA ALDOB ALDOC PON3 CBS	7.04e-06	50	213	6	CID009577953
Drug	1,3-dioxan-5-one	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID009793707
Drug	AC1L4F2K	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID000184526
Drug	gamma-oxalocitramalate	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID000000130
Drug	2,3-dihydroxy-p-cumate	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID000029587
Drug	AC1NX490	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID005743230
Drug	phosphoglycollamide	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID000191768
Drug	D-erythrulose 1-phosphate	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID000152153
Drug	hydroxypyruvaldehyde phosphate	ALDOA ALDOB ALDOC	7.96e-06	5	213	3	CID000193787
Drug	3-bromopyruvate	PDC HK3 GCK ALDOA ALDOB ALDOC	8.88e-06	52	213	6	CID000070684
Drug	AC1L494B	HK3 GCK PFKP ALDOA ALDOB ALDOC	9.94e-06	53	213	6	CID000181487
Drug	AC1L1A5Z	MYH6 GCK PFKP ACSL1 ALDOA ALDOB ALDOC CBS	9.95e-06	111	213	8	CID000000850
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	TRIO PTCH1 ITGB5 ALDOC KDM6A KIF13B STAB2 VPS50 ATP8B2 KIF20A	1.53e-05	194	213	10	1632_UP
Drug	mycestericin D	ALDOA ALDOB ALDOC	1.58e-05	6	213	3	CID006439504
Drug	C02783	ALDOA ALDOB ALDOC	1.58e-05	6	213	3	CID000439805
Drug	2,2-dimethyl-1,3-dioxan-5-one	ALDOA ALDOB ALDOC	1.58e-05	6	213	3	CID002733141
Drug	2-(N-decyl)aminonaphthalene-6-sulfonic acid	ALDOA ALDOB ALDOC	1.58e-05	6	213	3	CID000189836
Drug	parapyruvate	ALDOA ALDOB ALDOC	1.58e-05	6	213	3	CID000440249
Drug	acetyldithio-CoA	ALDOA ALDOB ALDOC	1.58e-05	6	213	3	CID003082679
Drug	3HPP	ALDOA ALDOB ALDOC CASR	1.61e-05	17	213	4	CID000000091
Drug	Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DLG5 GBF1 KDM6A MOK PNPLA2 ST3GAL4 ATP8B2 ATG3 MAPKBP1 USP33	1.75e-05	197	213	10	7231_DN
Drug	N(epsilon)-(carboxymethyl)lysine	GCLC ALB SELE MOK SLC26A3	1.77e-05	35	213	5	CID000123800
Drug	acenaphthenone	ALDOA ALDOB ALDOC	2.75e-05	7	213	3	CID000075229
Drug	DAPpNP	ALDOA ALDOB ALDOC	2.75e-05	7	213	3	CID005492375
Drug	5-deoxy-D-xylulose-1-phosphate	ALDOA ALDOB ALDOC	2.75e-05	7	213	3	CID000192931
Drug	Z-Glu-Tyr	ALDOA ALDOB ALDOC	2.75e-05	7	213	3	CID000096820
Drug	C0447	ALDOA ALDOB ALDOC	2.75e-05	7	213	3	CID000128786
Drug	1,6-di-o-phosphonohexopyranose	HK3 GCK PFKP ALDOA ALDOB ALDOC	2.98e-05	64	213	6	CID000000737
Drug	arabinopyranose	HK3 GCK UGDH ALB PLGLB1 ALDOA ALDOB ALDOC MOK GPC6 CBS	3.74e-05	261	213	11	CID000000229
Drug	3-hydroxy-4-oxobutyl-1-phosphonate	ALDOA ALDOB ALDOC	4.37e-05	8	213	3	CID003016813
Drug	L-rhamnulose-1-phosphate	ALDOA ALDOB ALDOC	4.37e-05	8	213	3	CID000439413
Drug	amorphin	ALDOA ALDOB ALDOC	4.37e-05	8	213	3	CID000122792
Drug	AC1L19C4	HK3 GCK PFKP ALDOA ALDOB ALDOC	4.58e-05	69	213	6	CID000000483
Drug	d-sedoheptulose 1,7-diphosphate	PFKP ALDOA ALDOB ALDOC	4.77e-05	22	213	4	CID000001193
Drug	pyruvic acid	PDC HK3 ACSS1 GCK PFKP GGT1 LDHD ALB PLGLB1 ALDOA ALDOB ALDOC SRR CBS	4.97e-05	424	213	14	CID000001060
Drug	4-amino-2,6-dinitrotoluene	ABCF1 HK3 KATNAL1 GGT1 FAT1 AP1G1 SACS GCLC UGDH XRN1 ALDOA CARM1 OAT ATP8B2 MLH3 ADAMTS7	5.40e-05	541	213	16	ctd:C035207
Drug	2-carboxybenzaldehyde	PDC ALDOA ALDOB ALDOC	5.74e-05	23	213	4	CID000008406
Drug	D -Adonose	UGDH ALDOA ALDOB ALDOC CBS	6.16e-05	45	213	5	CID000079021
Drug	AC1Q6BTB	GCK ALDOA ALDOC	6.51e-05	9	213	3	CID000000080
Drug	Fibrin	PLGLA PLG PLGLB1	6.51e-05	9	213	3	CID000439199
Drug	2-oxopentenoate	ALDOA ALDOB ALDOC	6.51e-05	9	213	3	CID000000976
Drug	4-heptadecyl-7-hydroxycoumarin	PDC CASR	8.71e-05	2	213	2	CID005491931
Drug	Ichiba acid	ALDOA ALDOC	8.71e-05	2	213	2	CID000440403
Drug	3-HM	ALDOA ALDOC	8.71e-05	2	213	2	CID000439464
Drug	bromohydroxyacetone phosphate	ALDOA ALDOC	8.71e-05	2	213	2	CID000152675
Drug	anthracene diol	ALDOA ALDOC	8.71e-05	2	213	2	CID000155464
Drug	tartronate semialdehyde	ALDOA ALDOB ALDOC	9.23e-05	10	213	3	CID000001122
Drug	SM-8	ALDOA ALDOB ALDOC	9.23e-05	10	213	3	CID000486037
Drug	AC1L2T2K	ALDOA ALDOB ALDOC CASR	9.47e-05	26	213	4	CID000128038
Drug	oxalocrotonate	DST ALDOA ALDOB ALDOC	9.47e-05	26	213	4	CID000440019
Drug	AC1Q6SXM	HK3 GCK PFKP ALDOA ALDOB ALDOC	9.84e-05	79	213	6	CID000000717
Drug	D-arabinitol	GCK PFKP UGDH ALDOA ALDOB ALDOC CBS	1.00e-04	114	213	7	CID000000827
Drug	SB 203580; Up 200; 1uM; MCF7; HT_HG-U133A	PTCH1 SACS ATAD2B ZNF324 QKI KDM6A KIF13B ATP8B2 MAPKBP1	1.08e-04	198	213	9	6915_UP
Drug	oxaloacetate	HK3 GCK PFKP GGT1 LDHD ALB ALDOA ALDOB ALDOC	1.08e-04	198	213	9	CID000000970
Drug	1H-n	PDC ALDOA ALDOB ALDOC	1.10e-04	27	213	4	CID000006844
Drug	AC1MRI6N	GCK ALDOA ALDOB ALDOC	1.10e-04	27	213	4	CID000417447
Drug	vinylidene chloride	CLEC5A GDAP2 ACSS1 HJURP GATA3 PFKP APOBR ITPR3 ACSL1 FAT1 DLC1 SACS ADAMTS15 KDR ALB SIPA1L2 NLRC3 DNASE1L1 NIBAN1 ANK2 CIP2A PON3 CASR SRR CLDN10 KIF20A SHCBP1 CADPS2 ECHDC2	1.22e-04	1475	213	29	ctd:C029297
Drug	diketone	ALDOA ALDOB ALDOC CASR	1.28e-04	28	213	4	CID000167775
Drug	panobinostat	MYLK GATA3 ZMYM2 PFKP ZC3H6 ITGB5 SYNPR ACSL1 LDHD DLC1 DST ARHGAP31 ADAMTS15 FGF8 KDR MAFB PDE11A PRSS12 SHB OVOS2 SEMA5A OAT GRIK3 PPM1K RUNX1T1 GPC6 SCUBE2	1.31e-04	1333	213	27	ctd:C496932
Drug	AC1NRA2O	MYLK ALB ALDOA ALDOB ALDOC GPSM1	1.38e-04	84	213	6	CID005287668
Drug	3'-Me-DAB	GGT1 ALB ALDOA ALDOB ALDOC	1.49e-04	54	213	5	CID000005934
Drug	AC1L4B0X	PDC HK3 HIPK1 GCK ALDOA ALDOB ALDOC	1.53e-04	122	213	7	CID000153769
Drug	AC1Q6RZ4	HK3 GCK PFKP LDHD ALDOA ALDOB ALDOC	1.61e-04	123	213	7	CID000000719
Drug	1trd	ALDOA ALDOB ALDOC	1.67e-04	12	213	3	CID000004797
Drug	dihydropteridine	ALDOA ALDOB ALDOC	1.67e-04	12	213	3	CID000000167
Drug	DL-ethionine	PLGLA GGT1 FAT1 ALB PLGLB1 CBS	1.68e-04	87	213	6	CID000006205
Drug	2-keto-3-deoxy-6-phosphogluconate	GCK ALDOA ALDOB ALDOC	1.69e-04	30	213	4	CID000000046
Drug	mg U	HK3 GCK PNPLA2 GRM4	1.69e-04	30	213	4	CID000445508
Drug	lead sulfide	HK3 GCK PFKP SAG DST XRN1 KDR ALB CARM1 HNRNPUL1	1.79e-04	260	213	10	CID000014819
Drug	2-hexulofuranose	HK3 GCK PFKP ALDOA ALDOB ALDOC	1.79e-04	88	213	6	CID000000716
Drug	anthranilic acid	METAP2 SHB CASR CCT7 ST3GAL4 RP1	1.90e-04	89	213	6	CID000000227
Drug	2,5-anhydro-D-mannitol	HK3 GCK PFKP MOK	1.92e-04	31	213	4	CID000001494
Drug	ketose	GCK ALDOA ALDOB ALDOC	1.92e-04	31	213	4	CID000439494
Disease	Colorectal Carcinoma	HK3 ABCA9 KRT73 FAT1 DLC1 SACS ADAMTS15 KDR QKI DNAH8 KDM6A WDR49 ANK2 GRIK3 RUNX1T1 MLH3 ACSL5	7.61e-06	702	202	17	C0009402
Disease	colorectal cancer (is_implicated_in)	ALX4 FAT1 DLC1 KDR KDM6A ITPKC MLH3	2.07e-05	121	202	7	DOID:9256 (is_implicated_in)
Disease	Cardiovascular Diseases	ALB SELE GRK5 CBS	1.06e-04	36	202	4	C0007222
Disease	gonadal dysgenesis (implicated_via_orthology)	STARD13 DLC1	2.77e-04	4	202	2	DOID:14447 (implicated_via_orthology)
Disease	apolipoprotein B to apolipoprotein A1 ratio	NLRC5 MAFB ST3GAL4 LCP1	3.55e-04	49	202	4	EFO_0021897
Disease	cortical surface area measurement	FILIP1 PTCH1 ITGB5 ALX4 POLR1F ARHGAP31 ATAD2B XRN1 METAP2 AGAP3 FNIP2 AKT3 ARRDC4 KIF26B PRSS12 SEMA5A NECTIN3 RUNX1T1 DNAH7 TG ADAMTS7	3.89e-04	1345	202	21	EFO_0010736
Disease	sick sinus syndrome (is_implicated_in)	MYH6 ANK2	4.60e-04	5	202	2	DOID:13884 (is_implicated_in)
Disease	kallikrein-7 measurement	CD163 CD163L1	4.60e-04	5	202	2	EFO_0008195
Disease	hyperinsulinemic hypoglycemia (implicated_via_orthology)	HK3 GCK	4.60e-04	5	202	2	DOID:13317 (implicated_via_orthology)
Disease	Epilepsy, Benign Psychomotor, Childhood	KCNC4 KDR GRM4	5.06e-04	23	202	3	C0393672
Disease	Epilepsy, Lateral Temporal	KCNC4 KDR GRM4	5.06e-04	23	202	3	C0393682
Disease	Uncinate Epilepsy	KCNC4 KDR GRM4	5.06e-04	23	202	3	C0014558
Disease	Epilepsy, Temporal Lobe	KCNC4 KDR GRM4	5.06e-04	23	202	3	C0014556
Disease	behavior	PTCH1 LDHD LCP1 SPATA13	5.53e-04	55	202	4	GO_0007610
Disease	coronary artery disease (is_implicated_in)	MYLK GCK ARHGAP31 SELE CBS	6.36e-04	100	202	5	DOID:3393 (is_implicated_in)
Disease	forced expiratory volume, environmental tobacco smoke exposure measurement	ACTBL2 GRIK3	6.87e-04	6	202	2	EFO_0004314, EFO_0008361
Disease	free cholesterol in IDL measurement	MAFB PLG ST3GAL4 LCP1	8.20e-04	61	202	4	EFO_0022181
Disease	Liver Cirrhosis, Experimental	STARD13 GCK PFKP CD163 ACSL1 FAT1 NLRC5 ALB PLG COL12A1 OAT SRR LCP1 SHCBP1	9.53e-04	774	202	14	C0023893
Disease	fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement	LCP1 GRM4	9.57e-04	7	202	2	EFO_0004612, EFO_0600007
Disease	migraine without aura, susceptibility to, 4, diastolic blood pressure	ITGB5 MEF2D	9.57e-04	7	202	2	EFO_0006336, MONDO_0011847
Disease	total lipids in very large HDL measurement	NLRC5 PLG PON3 LCP1	1.10e-03	66	202	4	EFO_0022312
Disease	phospholipids in very large HDL measurement	NLRC5 PLG PON3 LCP1	1.10e-03	66	202	4	EFO_0022298
Disease	Ischemic stroke, von Willebrand factor measurement	STAB2 HECTD4 ST3GAL4	1.12e-03	30	202	3	EFO_0004629, HP_0002140
Disease	Hantavirus hemorrhagic fever with renal syndrome (is_marker_for)	CD163 ALB	1.27e-03	8	202	2	DOID:11266 (is_marker_for)
Disease	cholesterol in very large HDL measurement	NLRC5 PLG PON3 LCP1	1.30e-03	69	202	4	EFO_0022229
Disease	von Willebrand factor measurement, coronary artery disease	STAB2 HECTD4 SEMA5A ST3GAL4 LCP1	1.34e-03	118	202	5	EFO_0001645, EFO_0004629
Disease	non-high density lipoprotein cholesterol measurement	GATA3 ABCA9 CD163 DLC1 CD163L1 XRN1 MAFB KIF13B ZNF329 ST3GAL4 LCP1 RP1 ECHDC2	1.34e-03	713	202	13	EFO_0005689
Disease	nucleotide measurement	SIPA1L2 DOCK2 AKT3 GRIK3	1.60e-03	73	202	4	EFO_0010513
Disease	factor VIII measurement, venous thromboembolism	STAB2 GRK5 ST3GAL4	1.62e-03	34	202	3	EFO_0004286, EFO_0004630
Disease	Uveitis	SAG ALB	1.63e-03	9	202	2	C0042164
Disease	underweight body mass index status	PSMB3 ANK2	1.63e-03	9	202	2	EFO_0005936
Disease	uveal melanoma (is_marker_for)	KDM5B KDR	1.63e-03	9	202	2	DOID:6039 (is_marker_for)
Disease	respiratory symptom measurement, COVID-19	FYCO1 FAT1 UGDH SCUBE2	1.69e-03	74	202	4	EFO_0007939, MONDO_0100096
Disease	esophagus squamous cell carcinoma (is_marker_for)	KDM5B PTCH1 FAT1 KDM6A	1.69e-03	74	202	4	DOID:3748 (is_marker_for)
Disease	low density lipoprotein cholesterol measurement, C-reactive protein measurement	CARM1 HECTD4 ST3GAL4	1.76e-03	35	202	3	EFO_0004458, EFO_0004611
Disease	maturity-onset diabetes of the young (implicated_via_orthology)	HK3 GCK	2.02e-03	10	202	2	DOID:0050524 (implicated_via_orthology)
Disease	free cholesterol to total lipids in large VLDL percentage	NLRC5 ST3GAL4 LCP1	2.07e-03	37	202	3	EFO_0022281
Disease	Unipolar Depression	CMYA5 KDR ALB PLG QKI PDE11A TG	2.13e-03	259	202	7	C0041696
Disease	free cholesterol in large HDL measurement	NLRC5 PLG PON3 LCP1	2.15e-03	79	202	4	EFO_0022157
Disease	Graves disease	ABCF1 ITPR3 NECTIN3 TG	2.35e-03	81	202	4	EFO_0004237
Disease	Cleft upper lip	PTCH1 FGF8 MAFB	2.41e-03	39	202	3	C0008924
Disease	triglycerides to total lipids in large VLDL percentage	NLRC5 ST3GAL4 LCP1	2.41e-03	39	202	3	EFO_0022332
Disease	liver cirrhosis (is_marker_for)	CD163 GGT1 KDR ALB	2.46e-03	82	202	4	DOID:5082 (is_marker_for)
Disease	Enzymopathy	GCLC ALDOA	2.46e-03	11	202	2	C0520572
Disease	factor VIII measurement	STAB2 ST3GAL4 RP1	2.59e-03	40	202	3	EFO_0004630
Disease	Arthritis, Collagen-Induced	ACSL1 ALB ACSL5	2.59e-03	40	202	3	C0971858
Disease	Arthritis, Experimental	ACSL1 ALB ACSL5	2.59e-03	40	202	3	C0993582
Disease	Arthritis, Adjuvant-Induced	ACSL1 ALB ACSL5	2.59e-03	40	202	3	C0003865
Disease	metabolic syndrome	GCK MAFB PLG HECTD4 ST3GAL4 LCP1	2.63e-03	200	202	6	EFO_0000195
Disease	serum alanine aminotransferase measurement	DLG5 GBF1 CMYA5 PTCH1 MEF2D MAFB USP48 ALDOB COL12A1 HECTD4 GRIK3 USP21 ADAMTS7 RP1	2.78e-03	869	202	14	EFO_0004735
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	GBF1 GCK MAFB PLG PON3 ST3GAL4 LCP1	2.92e-03	274	202	7	EFO_0004530, EFO_0004612
Disease	venous thromboembolism, von Willebrand factor measurement	STAB2 GRK5 ST3GAL4	2.98e-03	42	202	3	EFO_0004286, EFO_0004629
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	GCK NLRC5 MAFB PLG ST3GAL4 LCP1	3.04e-03	206	202	6	EFO_0004612, EFO_0020947
Disease	coronary artery disease	HNRNPM ITGB5 DLC1 CLIC5 MAFB PLG USP48 DNASE1L1 TBCD HECTD4 SEMA5A ST3GAL4 HNRNPUL1 LCP1 ADAMTS7 RP1 GPSM1	3.64e-03	1194	202	17	EFO_0001645
Disease	Malformations of Cortical Development	TBCD AKT3	4.02e-03	14	202	2	C1955869
Disease	thalamus volume change measurement	FAT1 KIF26B	4.02e-03	14	202	2	EFO_0021496
Disease	Cortical Dysplasia	TBCD AKT3	4.02e-03	14	202	2	C0431380
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	MAFB PLG ST3GAL4 LCP1	4.02e-03	94	202	4	EFO_0008595, EFO_0010351
Disease	free cholesterol in small VLDL measurement	MAFB ST3GAL4 LCP1	4.11e-03	47	202	3	EFO_0022272
Disease	free cholesterol in medium VLDL measurement	MAFB ST3GAL4 LCP1	4.11e-03	47	202	3	EFO_0022269
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	NLRC5 MAFB PLG ST3GAL4 LCP1	4.13e-03	153	202	5	EFO_0004611, EFO_0020946
Disease	calcium measurement	GATA3 ZMYM2 ABCA9 GGT1 SAG MAFB ALB MYO18B GRK5 CASR ST3GAL4	4.19e-03	628	202	11	EFO_0004838
Disease	Alobar Holoprosencephaly	PTCH1 FGF8	4.62e-03	15	202	2	C0431363
Disease	ghrelin measurement	STARD13 ALX4 AKT3	4.62e-03	49	202	3	EFO_0600001
Disease	cholesteryl esters to total lipids in small VLDL percentage	NLRC5 ST3GAL4 LCP1	4.62e-03	49	202	3	EFO_0022256
Disease	mean platelet volume	PFKP APOBR ACSL1 UBN1 ATAD2B TASOR WDR49 TBCD NIBAN1 GRK5 CASR ST3GAL4 LCP1 ARPIN ACSL5	4.63e-03	1020	202	15	EFO_0004584
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	MAFB PLG ST3GAL4 LCP1	4.84e-03	99	202	4	EFO_0004574, EFO_0008595
Disease	free cholesterol in LDL measurement	MAFB ST3GAL4 LCP1	4.89e-03	50	202	3	EFO_0022266
Disease	free cholesterol in large LDL measurement	MAFB ST3GAL4 LCP1	5.17e-03	51	202	3	EFO_0022176
Disease	Schizoaffective disorder-bipolar type	PTCH1 STAB2	5.25e-03	16	202	2	EFO_0009965
Disease	Urticaria	ALB SELE	5.25e-03	16	202	2	C0042109
Disease	Lobar Holoprosencephaly	PTCH1 FGF8	5.25e-03	16	202	2	C0431362
Disease	Semilobar Holoprosencephaly	PTCH1 FGF8	5.25e-03	16	202	2	C0751617
Disease	phospholipids in medium VLDL measurement	MAFB ST3GAL4 LCP1	5.46e-03	52	202	3	EFO_0022154
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	MAFB PLG ST3GAL4 LCP1	5.75e-03	104	202	4	EFO_0008591, EFO_0008595
Disease	cholesterol in small VLDL measurement	MAFB ST3GAL4 LCP1	5.76e-03	53	202	3	EFO_0022228
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	GCK MAFB PLG ST3GAL4 LCP1	5.82e-03	166	202	5	EFO_0004530, EFO_0004611
Disease	neuroticism measurement, cognitive function measurement	AGO2 PTCH1 SYNPR RUNDC3A KIF27 GRIK3 THSD7B TG SCUBE2 USP33	5.87e-03	566	202	10	EFO_0007660, EFO_0008354
Disease	Holoprosencephaly	PTCH1 FGF8	5.93e-03	17	202	2	C0079541
Disease	fatty liver disease (is_marker_for)	CD163 GGT1	5.93e-03	17	202	2	DOID:9452 (is_marker_for)
Disease	hyperglycemia (implicated_via_orthology)	HK3 GCK	5.93e-03	17	202	2	DOID:4195 (implicated_via_orthology)
Disease	Small cell carcinoma of lung	MYO18B GRIK3 RUNX1T1	6.07e-03	54	202	3	C0149925
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	NLRC5 MAFB ST3GAL4 LCP1	6.36e-03	107	202	4	EFO_0004614, EFO_0004615
Disease	parathyroid hormone measurement	MAFB CASR GRIK3	6.38e-03	55	202	3	EFO_0004752
Disease	high density lipoprotein particle size measurement	NLRC5 PLG PON3 ST3GAL4 LCP1	6.42e-03	170	202	5	EFO_0008592
Disease	migraine disorder, systolic blood pressure	ITGB5 MEF2D	6.64e-03	18	202	2	EFO_0006335, MONDO_0005277
Disease	triglycerides to total lipids in medium HDL percentage	NLRC5 PLG LCP1	6.71e-03	56	202	3	EFO_0022333
Disease	free cholesterol to total lipids in large HDL percentage	PLG PON3 LCP1	6.71e-03	56	202	3	EFO_0022279
Disease	cholesteryl esters to total lipids in medium HDL percentage	NLRC5 PLG LCP1	6.71e-03	56	202	3	EFO_0022251
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	NLRC5 MAFB PLG KIF27 PON3 LCP1	6.74e-03	243	202	6	EFO_0004612, EFO_0020944

Protein segments in the cluster

Peptide	Gene	Start	Entry
VTKKQLGAGSREECA	PLGLB1	36	Q02325
CEGKERQKLALIGDS	SYNPR	61	Q8TBG9
AAKAQGFGDAKSRAR	ALX4	51	Q9H161
KKAAECKVDSIGSGR	AGAP3	351	Q96P47
CKLSGGQKARVVFAE	ABCF1	741	Q8NE71
AESLAGRINDAKCKV	ACSS1	201	Q9NUB1
CFAEEGKKLVAASQA	ALB	591	P02768
KDCYVGDEAQSKRGV	ACTBL2	51	Q562R1
QGLDGLSERCAQYKK	ALDOC	126	P09972
QGLDGLSERCAQYKK	ALDOB	126	P05062
ECIGSALIQKGFKTA	ACSL1	131	P33121
KGEKGARGNDCVRIS	COL16A1	351	Q07092
AGKCERVEALKGVVF	ABCA9	491	Q8IUA7
RGLFTNGSCADIKKV	CASR	441	P41180
QGLDGLSERCAQYKK	ALDOA	126	P04075
KSREDGGVCIAQSVK	GRM4	241	Q14833
GCQAGAELEELSKKA	GZF1	281	Q9H116
GVATNAAKVLEEKGC	ABHD12B	221	Q7Z5M8
QDSGKSCGVDFEVKA	SAG	141	P10523
AQKCSKGAAAEIREQ	ARPIN	201	Q7Z6K5
RLFCADKTERVGKSG	AGO4	716	Q9HCK5
DGKAKRTCFRRSDAG	CD163L1	451	Q9NR16
VGGSDKAKAKIACLA	CLDN10	106	P78369
ANTCGEDKGSRRKFL	CLIC5	321	Q9NZA1
ACKAKTDAGGEDAIL	ATG3	181	Q9NT62
KAGCDGNLGSKKRFD	ADAMTS15	656	Q8TE58
KLDAAVDGTRCGENK	ADAMTS7	506	Q9UKP4
FCTDKNERVGKSGNI	AGO2	716	Q9UKV8
KITDFGLCKEGITDA	AKT3	286	Q9Y243
SLSAKIERKGYCNGE	ARRDC4	196	Q8NCT1
GDISKLAKFDGEVIC	ATP8B2	206	P98198
VKGTGALRDCKNVLD	HJURP	331	Q8NCD3
FGDCLVRSKGAVAIA	RANGAP1	271	P46060
DSGVGKTCLLVRFKD	RAB26	71	Q9ULW5
SLENVGCASQIGKRK	PPM1K	91	Q8N3J5
GCASQIGKRKENEDR	PPM1K	96	Q8N3J5
GTKKDLLSGAACEQA	RAB36	236	O95755
RGLTAKQLEAETGCK	QKI	106	Q96PU8
GFRIEGIKKADGTCN	ITPKC	551	Q96DU7
GRGAALVSAVACKKA	GCK	446	P35557
IAATQCRLDKEGATK	ITPR3	1721	Q14573
GKNCVAIAADRRFGI	PSMB3	16	P49720
CEALAVGRSSEKEGK	ANK2	1666	Q01484
FKADCASGIFLAAEK	AP1G1	396	O43747
KDAGGKVAFCTVNVI	FAT1	2571	Q14517
GCRTGEAKLTKGFNL	GDAP2	106	Q9NXN4
CLGEAGAKFIEVSKE	PNPLA2	61	Q96AD5
DKDAAVICRQLGYKG	PRSS12	531	P56730
NLCIKEGATAKFEGR	MYLK	41	Q15746
KKGICEALEDSDGRQ	MATN2	831	O00339
SETFLVGNVDECGKK	METAP1D	191	Q6UB28
VKCEKLANSGFREAG	MAFB	296	Q9Y5Q3
KDATNTGIKCAGIDV	METAP2	281	P50579
AEQRGDCALKDARAK	KRT73	381	Q86Y46
GDDGACAVARALKVN	NLRC3	931	Q7RTR2
ALSLVIGDCRKKGNF	RUNX1T1	11	Q06455
ERLCKAGDFKTGVAF	GPSM1	36	Q86YR5
CGLKRKSEEVDSNGS	HIPK1	121	Q86Z02
LEAAKSCSKRDGGKV	DST	3991	Q03001
ACLAKVKGANDGIRF	FYCO1	76	Q9BQS8
ARALANECSQGDKKV	ATAD2B	451	Q9ULI0
DLGSCVKALSKNREG	KIF26B	711	Q2KJY2
VKALSKNREGGSGLC	KIF26B	716	Q2KJY2
LRSNAGAEKGKEIAA	KIAA1109	1806	Q2LD37
VKGVFCAGADLKERE	ECHDC2	86	Q86YB7
DAEGKSRGCAVVEFK	HNRNPM	106	P52272
KAEGKVESDFFCQLG	KDM6A	86	O15550
TDFKDKIVLDVGCGS	CARM1	181	Q86X55
DKDRDGFISCKDLGN	CABP5	41	Q9NP86
QEESRVKCKNCGAFG	FAM90A27P	36	A6NNH2
DACNLKRRKGSFGSI	KIF27	901	Q86VH2
AGCNKIGNFSTDIKD	LCP1	281	P13796
KFCKIKASNTGAGDR	PDC	166	P20941
SGKALKACEADVTRA	MLH3	126	Q9UHC1
LCFSVNGVFKEVDGK	NXF1	491	Q9UBU9
DRCSLFLVEGAAAGK	PDE11A	236	Q9HCR9
EEGKGVFDCRKNVLG	PFKP	656	Q01813
TFESAKKVCGNVAGL	DNAH8	3256	Q96JB1
FRKDICKGGNAVVDG	GCLC	486	P48506
DCGIFVTKVDKGSIA	DLG5	651	Q8TDM6
GDQRKKACLSALSEV	PI4KAP1	221	Q8N8J0
FSCEQGFVLKGSKRL	SELE	396	P16581
RAAGKCDAVFKGFSD	NRN1	26	Q9NPD7
EKNDCCRGKRDGINS	KDM5B	1391	Q9UGL1
IKQDVLKLGDFGSCR	MOK	136	Q9UQ07
FLICTEGAKASKQGV	OVOS2	906	Q6IE36
RKACNAHGGVFKDEI	HECTD4	2996	Q9Y4D8
TKGFKASDCEGQDVV	HK3	626	P52790
RKCEGLKIGDTASFE	ITGB5	411	P18084
VTKKQLGAGSREECA	PLGLA	36	Q15195
GQIENLSFKSRKCGD	NLRC5	686	Q86WI3
RKQEECLFFLKGTEG	CCDC181	436	Q5TID7
AKSNGKGKDCVFTEI	FGF8	136	P55075
GSAGSARQDEKECLK	GATA3	171	P23771
IGIFRKNGGKATESC	HENMT1	226	Q5T8I9
KARSCGEVRQAYGAK	GPC6	26	Q9Y625
GDFNADCASLTKKRL	DNASE1L1	181	P49184
DLKDTGAKKCTQGLR	DOCK2	306	Q92608
LLGSQGVCKDSKDLF	COLCA1	56	Q6ZS62
KVDFVCDEGFQLKGS	CR1	381	P17927
KVDFVCDEGFQLKGS	CR1	831	P17927
RGCGDVEDSNKNLKE	CPLANE1	2101	Q9H799
VCKGAKADIVFLTDA	COL12A1	2316	Q99715
VKADNSLAVRAGGCF	DHH	186	O43323
SAEGKCEKGLDNAVV	FRMPD4	856	Q14CM0
PCGDDNKKANFRTEG	FNIP2	871	Q9P278
FGTICREKSLEEQKG	CMYA5	3286	Q8N3K9
QKAKGELCRDFVEAL	LDHD	21	Q86WU2
KACKTEADGRVVEGN	CYTH2	336	Q99418
TDGARLKKCFNKVTG	DEFB128	16	Q7Z7B8
EKIRNASTAAEGLCK	DNAH7	2781	Q8WXX0
LAKCEFFNAGGSVKD	CBS	106	P35520
KGQVIKACKTEADGR	CYTH3	336	O43739
KACKTEADGRVVEGN	CYTH3	341	O43739
FAAKLGVKGSFEELC	ACSL5	596	Q9ULC5
GGCSANDFREVFKKN	CADPS2	166	Q86UW7
DICEGKVKAASGGFR	MBOAT4	136	Q96T53
NNLFTDVACGRGKKA	MAPKBP1	231	O60336
DVACGRGKKADSTFC	MAPKBP1	236	O60336
IKCERKDDFLGAAEG	CDCA2	761	Q69YH5
CDRKANVAILFSGGI	ASNSD1	316	Q9NWL6
FVEASLNGGCKSQEK	GBF1	1421	Q92538
KAREGKSFDIFCDVG	CYP4B1	171	P13584
SFEATKKACDQLALG	GRIK3	91	Q13003
KDAKQRLGCQEEGAA	GRK5	426	P34947
GTDKELRLVDGENKC	CD163	46	Q86VB7
GFTLQLDGKTCKDID	SCUBE2	311	Q9NQ36
CAVNDVGKGQFSKDT	SDK2	666	Q58EX2
SSVKLGFEEAGCKQI	SACS	2031	Q9NZJ4
FIGVDDKSRKVLGCA	SLFN13	246	Q68D06
VGAEFNKDDCVKRGE	C9	396	P02748
NKDDCVKRGEGRAVN	C9	401	P02748
EGKQAGKSRSDCREN	GARNL3	566	Q5VVW2
GLENALSKGREKCSA	IRGQ	361	Q8WZA9
ETLRKKGFNGCDSPE	MEF2D	86	Q14814
ECGNDVELSFTKNGK	HNRNPUL1	336	Q9BUJ2
KDRDSGENGKTICYV	PCDHB9	371	Q9Y5E1
LTGDNLCKEGDKSFI	RP1	981	P56715
LCKEGDKSFIANDTG	RP1	986	P56715
GDAAEGRAAKRCEKA	MRFAP1	86	Q9Y605
LQSSGIKVGDDKCFL	KIF13B	436	Q9NQT8
DFSFCLKGEVLDGKT	RUNDC3A	181	Q59EK9
ICDNAKKGREYALLG	KATNAL1	6	Q9BW62
CLDQVGLFRKSGVKS	STARD13	691	Q9Y3M8
DKKAKVGLEACGRAQ	TRIM42	546	Q8IWZ5
LFQAGDVCGISSRKK	SVOP	341	Q8N4V2
GGKKLLNKCAASAAE	SHB	216	Q15464
AAFASKFQVAGKGRC	SSPOP	721	A2VEC9
KFQVAGKGRCPSEDS	SSPOP	726	A2VEC9
IGRLEVKCKNADAGC	RNF151	76	Q2KHN1
ELRDKIAKGECGNSS	FILIP1	361	Q7Z7B0
ELFKDAEGKSRGCGV	MYEF2	131	Q9P2K5
AEGKSRGCGVVEFKD	MYEF2	136	Q9P2K5
LGFGVAAKSTQDCRK	NIP7	141	Q9Y221
AGALQRICEVEKKDG	FASTKD3	131	Q14CZ7
CDAAFALEQISKGKA	PTCH1	56	Q13635
LGSYKERALQKDGSC	SIPA1L2	1191	Q9P2F8
CLQGEAESKASKLFG	ST3GAL4	46	Q11206
KAKTCTFILRGGAEQ	CCT7	366	Q99832
GCDFKNRFKVAVVGD	SLC26A3	306	P40879
KRGKGDTFVDCTGAD	SHCBP1	416	Q8NEM2
CELFQKTGSFKIRGA	SRR	46	Q9GZT4
ASIAAIGDRGKKDNA	MYH6	196	P13533
LKKAFGLTSCAVEGR	OR6B3	301	Q8NGW1
VTKKQLGAGSIEECA	PLG	36	P00747
CLDQVGLFRKSGVKS	DLC1	1106	Q96QB1
TGVEAGETACKLARK	OAT	141	P04181
ECLKTGNRKAFAGEL	SMCR8	181	Q8TEV9
VFSRAARVCKNDIGG	SEMA5A	246	Q13591
NLIQCRKKSVGGDSD	TASOR	686	Q9UK61
LEARKKSKAGSGACQ	APOBR	136	Q0VD83
GFGTKVADSELCKLA	CIP2A	461	Q8TCG1
RDFCKGKGSTLAIVN	CLEC5A	96	Q9NY25
KKQEGIVGSSRVCFA	CLCN3	721	P51790
CEGLEKAIFQLKSGT	PIGA	356	P37287
DLGDGRDKDCNLSVK	SPATA13	511	Q96N96
EGYANVKKCSNEGRA	VPS50	861	Q96JG6
GLKEVVESCRGKNLF	UGDH	56	O60701
SDCGKAFGRRANLFK	ZFP92	351	A6NM28
DVCGKEFARGSDLVK	ZNF48	306	Q96MX3
KDCGKVFGSNRNLID	ZNF197	681	O14709
KDCGKAFGRTSELIL	ZNF565	266	Q8N9K5
GGKVSLRDCFNLFTK	USP21	411	Q9UK80
VDCGKAFAKGAVLLS	ZNF324	456	O75467
FLEGRCIKGDQCKFD	ZC3H6	281	P61129
GAAEAGRRKKAEAAA	ZCCHC3	116	Q9NUD5
SDRQKTEGCRLQAGK	SYNPO2	291	Q9UMS6
SSQLDEGKCAYIRGK	NIBAN1	6	Q9BZQ8
GSERCKDQKSGERLK	KIF20A	411	O95235
DADARSKALLGVCVG	UFSP1	66	Q6NVU6
QKAKEGNGCRKTFSR	ZNF274	476	Q96GC6
CFLKARKNTAVTGGA	WDR49	376	Q8IV35
EEVRFGGKKTQRVCA	XRN1	226	Q8IZH2
GRAAGKAVSCAEIVK	RPP25L	61	Q8N5L8
NECECKKGFRGNGID	STAB2	936	Q8WWQ8
EVKVVAKGFCSANGI	PON3	211	Q15166
KRKGAASAFGCDLTE	ARHGAP31	11	Q2M1Z3
SDAAGVFCIRGKLNI	POLR1F	186	Q3B726
KECGKAFGSRSDLIR	ZNF829	411	Q3KNS6
AECGKAFTDRSNLNK	ZNF585A	721	Q6P3V2
RLCAAFEKKGAGTEG	MYO18B	1056	Q8IUG5
NKKDLSICGSSGEEF	ZNF770	436	Q6IQ21
KGATKELDGVVRDFC	ZMYM2	736	Q9UBW7
KECGKTFFRGSELNR	ZNF790	481	Q6PG37
VGGVLCTEEKRNFAK	UBN1	706	Q9NPG3
DECGKAFRNNSGLKV	ZFP62	536	Q8NB50
ECKECGKSFIRGSQL	ZNF420	476	Q8TAQ5
KALTYDEKRGACSVG	TBCD	446	Q9BTW9
ALYKCEAVNKVGRGE	KDR	526	P35968
EGLRFRAVACSDKNG	THSD7B	961	Q9C0I4
CGKTVIAKNFADTLG	VWA8	451	A3KMH1
GLKDSLSDIGCKFVF	VN1R3	71	Q9BXE9
DDPNCERRKKNSFVG	USP48	76	Q86UV5
ASQKDRGSGKAFCVD	TG	1531	P01266
DKRTGDSDACGKGFN	ZNF329	116	Q86UD4
VERFGKSKDGSQCGE	ZNF44	116	P15621
QFFLDCGGLARTDKK	USP33	211	Q8TEY7
ELGRGRFSVVKKCDQ	TRIO	2801	O75962
DKCGKAFKQGSLLTR	ZNF836	501	Q6ZNA1
ECGKAFGKQSILNRH	ZNF181	241	Q2M3W8
VCKECGKAFRGNSEL	ZFP3	366	Q96NJ6
AAVAADAKQCSKIGR	GGT1	41	P19440
DRNKKAAACFLLSTG	KCNC4	581	Q03721
AAGGSRKLIDCKAEG	MXRA5	2456	Q9NR99
FVGRKGVNLKCNADA	NECTIN3	281	Q9NQS3